Sparagana M
Medical Service, Veterans Administration Hospital, Hines, Illinois.
J Surg Oncol. 1987 Nov;36(3):198-205. doi: 10.1002/jso.2930360310.
Two patients with mesenchymal tumors had osteomalacia associated with marked hypophosphatemia and renal phosphate wasting. Their serum calcium and parathyroid hormone levels were normal. The first patient also had aminoaciduria and glucosuria in addition to phosphaturia. Both patients were treated with very large doses of vitamin D2 and phosphate without improvement in the osteomalacia or normalization of the serum phosphate. Complete removal of a low-grade fibrosarcoma in the second patient and removal of an ossifying fibroma in the first patient resulted in a cure in both patients despite no further therapy with vitamin D or phosphate. The excessive aminoaciduria and glucosuria of the first patient also remitted. During a 14-year follow-up period, there has been no evidence of tumor recurrence, hypophosphatemia, or osteomalacia in either patient. The levels of 1,25-dihydroxycholecalciferol remain within the normal range in both patients.
两名间充质肿瘤患者患有骨软化症,伴有明显的低磷血症和肾性磷酸盐流失。他们的血清钙和甲状旁腺激素水平正常。第一名患者除了磷酸盐尿外,还存在氨基酸尿和糖尿。两名患者均接受了大剂量维生素D2和磷酸盐治疗,但骨软化症未改善,血清磷酸盐也未恢复正常。第二名患者的低度纤维肉瘤被完全切除,第一名患者的骨化性纤维瘤被切除,尽管未再进行维生素D或磷酸盐治疗,但两名患者均得以治愈。第一名患者过多的氨基酸尿和糖尿也消失了。在14年的随访期内,两名患者均无肿瘤复发、低磷血症或骨软化症的迹象。两名患者的1,25 - 二羟胆钙化醇水平均保持在正常范围内。